How often do you take a maintenance dose of Mounjaro?

The myth: maintenance means a different injection schedule

One of the most common misunderstandings our prescribers hear is that reaching a "maintenance dose" triggers some kind of change in how often you inject. It doesn't. Mounjaro is once weekly from day one, and once weekly it stays. The word "maintenance" refers exclusively to the strength level you have reached and are staying on, not a new frequency, not a top-up injection, not a booster. Seven days between each injection, every time, at every dose.

That seven-day interval matters. Injecting sooner doesn't accelerate results and significantly raises the risk of side effects. Leaving a longer gap disrupts the steady-state concentration the medicine builds up in your system. Your Mounjaro maintenance dose is designed to be effective at that weekly rhythm, the pharmacology depends on it. If you miss a dose, the right step is to check the Patient Information Leaflet and speak to your prescriber about timing, not to double up or guess.

The NHS medicines page for tirzepatide confirms the once-weekly schedule throughout treatment. If you have any uncertainty about your own timing, that page and your prescriber are the definitive references, not forums or social media.

What "maintenance dose" actually means in practice

Mounjaro is started at 2.5mg. That first pen is a tolerability dose, its job is to let your body adjust to the medicine rather than to produce significant weight loss. From there, doses are typically stepped up every four weeks: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg are the UK-licensed strengths. Your prescriber determines when (or whether) each increase is appropriate based on how you are tolerating the current dose and how your weight is responding.

Your maintenance dose is simply the dose you stay on once titration is complete. For some people that is 10mg; for others it is 15mg. A smaller number find 5mg is where they are best balanced between results and tolerability. There is no universally correct maintenance strength, which is why a prescriber assesses this individually. If you are wondering whether 5mg counts as a maintenance dose, the short answer is yes, for the right person, it absolutely can be.

On the question of results at maintenance, the SURMOUNT-1 trial (published in the New England Journal of Medicine) reported average body-weight reductions of around 20–21% at 15mg over 72 weeks in adults without diabetes. Those figures are clinical trial averages, individual results vary, and weight loss on maintenance is covered in more detail on the dedicated page about weight loss at maintenance dose.

How long you stay at maintenance, and what happens next

This is the question people rarely think to ask until they are already there. Mounjaro is not a short course. For most people who respond well, the expectation from their prescriber is that treatment continues at the maintenance dose for as long as it remains clinically appropriate and they are seeing benefit. Stopping abruptly tends to lead to weight regain, because the underlying biology that the medicine is addressing does not simply resolve after a few months.

If you are curious about the longer-term picture, our page on how long you stay on a Mounjaro maintenance dose covers the evidence and what your prescriber will typically monitor. The short version: there is no fixed endpoint built into the licence. Clinical review at each repeat is how the decision stays appropriate over time.

It is also worth knowing that if a particular strength stops feeling effective (which some people describe as a plateau) that is a conversation for your prescriber rather than a reason to self-adjust timing or frequency. The phenomenon sometimes called the "golden dose" not working has a real basis and real clinical options behind it.

Getting the dose right, what the clinical process looks like

We understand that if you are researching this, you might be trying to plan ahead or make sense of advice you have already received. That is completely reasonable. The titration schedule can feel slow, particularly if you are not yet seeing the results you hoped for at a lower dose.

What the clinical evidence and the UK prescribing framework both support is a gradual approach (roughly four-week intervals between increases) because that pacing genuinely reduces the severity of gastrointestinal side effects like nausea and indigestion, which are the main reason people stop treatment early. The starter dose period is frustrating for some, but it serves a purpose that pays off later.

Cost is also a real consideration for many people, and if you are weighing up what private treatment involves financially, our Mounjaro cost guide covers what private prices typically include and what to check before committing to a provider. For a prescription medicine, the right question is rarely which option costs the least, it is whether the clinical oversight matches the price.

If you are thinking about starting, or want a prescriber to review your current dose and schedule, check your eligibility with our clinical team. Every assessment is reviewed the same day by a GPhC-registered prescriber, a real clinician reading your answers, not automated software.